NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - Neuro …, 2013 - academic.oup.com
Background The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …
被引用次数：98 相关文章

NABTT 0502: A phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye… - Neuro …, 2013 - pure.johnshopkins.edu
Background. The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …
[PDF] psu.edu

[PDF][PDF] NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - Neuro-Oncology, 2013 - Citeseer
Background. The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …
[PDF] researchgate.net

[PDF][PDF] NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - Neuro …, 2013 - researchgate.net
Background. The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - Neuro …, 2013 - europepmc.org
Background The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …
[HTML] nih.gov

[HTML][HTML] NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - Neuro …, 2013 - ncbi.nlm.nih.gov
Background The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye… - Neuro …, 2013 - pubmed.ncbi.nlm.nih.gov
Background The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - Neuro …, 2013 - europepmc.org
Background The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …
[PDF] psu.edu

[PDF][PDF] NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - 2013 - Citeseer
Background. The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …
[PDF] researchgate.net

[PDF][PDF] NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

DM Peereboom, MS Ahluwalia, X Ye, JG Supko… - Neuro …, 2013 - researchgate.net
Background. The signal transduction pathways of epidermal growth factor receptor and Ras
are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that …